Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI
NCT04063800
·
clinicaltrials.gov ↗
COMPLETED
Status
195
Enrollment
OTHER
Sponsor class
Conditions
Prostatic Adenocarcinoma
Sponsor
University Hospital, Brest